Lymphocyte subsets in hemophilic patients with hepatitis C virus infection with or without human immunodeficiency virus co-infection: A nested cross-sectional study

BMC Blood Disorders

Volumn 5, Issue , 2005, Pages

  Zhang, Mingdong ^a   O'Brien, Thomas R ^a   Kopp, William C ^b   Goedert, James J ^a   Rosenberg, P S ^a,c   Rabkin, C S ^a,c   Engels, E A ^a,c   Whitby, D ^a,c   Eyster, M E ^d   Konkle, B ^e   Manco Johnson, M ^f   DiMichele, D ^g   Hilgartner, M W ^g   Blatt, P ^h   Aledort, L M ⁱ   Seremetes, S ⁱ   Hoots, K ^j   Angiolillo, A L ^k   Luban, N L C ^k   Cohen, A ^l   Manno, C S ^l   Leissinger, C ^m   White II, G C ⁿ   Lederman, M M ^o   Purvis, S ^o   Salkowitz, J ^o   Kessler, C M ^p   Karafoulidou, A ^q   Mandalaki, T ^q   Hatzakis, A ^r   Touloumi, G ^r   Schramm, W ^s   Rommel, F ^s   de Moerloose, P ^t   Eichinger, S ^u   Sherman, K E ^v   Kroner, B L ^w   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^e Cardeza Foundation   (United States)

^f UNIVERSITY OF COLORADO   (United States)

^g NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^h CHRISTIANA HOSPITAL   (United States)

ⁱ MOUNT SINAI MEDICAL CENTER   (United States)

^j UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^k CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^l CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^m TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ UNIVERSITY OF NORTH CAROLINA   (United States)

^o CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^q LAIKO GENERAL HOSPITAL   (Greece)

^r UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^s LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^t GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^u MEDICAL UNIVERSITY OF VIENNA   (Austria)

^v UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^w RTI INTERNATIONAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9 CONCENTRATE; CD19 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; VIRUS RNA;

ADULT; ARTICLE; B LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED STUDY; CRYOPRESERVATION; FLOW CYTOMETRY; HELPER CELL; HEMOPHILIA; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHESIS; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PROSPECTIVE STUDY; SUPERINFECTION; SUPPRESSOR CELL;

EID: 13644250284     PISSN: 14712326     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2326-5-2     Document Type: Article

References (17)

1. Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M, Maggi E, Romagnani S, Gentilini P, Brechot C: Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 1992, 15:382-386.
2. Wang JT, Sheu JC, Lin JT, Wang TH, Chen DS: Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells. J Infect Dis 1992, 166:1167-1169.
3. Laskus T, Radkowski M, Piasek A, Nowicki M, Horban A, Cianciara J, Rakela J: Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes. J Infect Dis 2000, 181:442-448.
4. Ferri C, Pileri S, Zignego AL: Hepatitis C virus, B-cell disorders, and non-Hodgkin's lymphoma. In Infectious Causes of Cancer: Targets for Intervention Edited by: Goedert JJ. Towota, NJ: Humana Press, Inc; 2000:349-368.
5. Yokozaki S, Takamatsu J, Nakano I, Katano Y, Toyoda H, Hayashi K, Hayakawa T, Fukuda Y: Immunologic dynamics in hemophiliac patients infected with hepatitis C virus and human immunodeficiency virus: influence of antiretroviral therapy. Blood 2000, 96: 293-4299.
6. Goedert JJ, Eyster ME, Lederman MM, Mandalaki T, De Moerloose P, White GC 2nd, Angiolillo AL, Luban NL, Sherman KE, Manco-Johnson M, Preiss L, Leissinger C, Kessler CM, Cohen AR, DiMichele D, Hilgartner MW, Aledort LM, Kroner BL, Rosenberg PS, Hatzakis A: End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood 2002, 100:1584-1589.
7. Goedert JJ, Hatzakis A, Sherman KE, Eyster ME: Lack of association of hepatitis C virus load and genotype with risk of end-stage liver disease in patients with human immunodeficiency virus coinfection. J Infect Dis 2001, 184:1202-1205.
8. Taylor JM, Fahey JL, Detels R, Giorgi JV: CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. J Acquir Immune Defic Syndr 1989, 2:114-124.
9. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S: Binding of hepatitis C virus to CD81. Science 1998, 282: 38-941.
10. Morsica G, Tambussi G, Sitia G, Novati R, Lazzarin A, Lopalco L, Mukenge S: Replication of hepatitis C virus in B lymphocytes (CD19+). Blood 1999, 94:1138-1139.
11. Zehender G, Meroni L, De Maddalena C, Varchetta S, Monti G, Galli M: Detection of hepatitis C virus RNA in CD19 peripheral blood mononuclear cells of chronically infected patients. J Infect Dis 1997, 176:1209-1214.
12. Sung VM, Shimodaira S, Doughty AL, Picchio GR, Can H, Yen TS, Lindsay KL, Levine AM, Lai MM: Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol 2003, 77: 134-2146.
13. Farci P, Shimoda A, Wong D, Cabe zon T, De Gioannis D, Strazzera A, Shimizu Y, Shapiro M, Alter HJ, Purcell RH: Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci U S A 1996, 93:15394-15399.
14. Crotta S, Stilla A, Wack A, D'Andrea A, Nuti S, D'Oro U, Mosca M, Filliponi F, Brunetto RM, Bonino F, Abrignani S, Valiante NM: Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med 2002, 195:35-41.
15. Tseng CT, Klimpel GR: Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med 2002, 195:43-49.
16. Chang KM, Thimme R, Melpolder JJ, Oldach D, Pemberton J, Moorhead-Loudis J, McHutchison JG, Alter HJ, Chisari FV: Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology 2001, 33:267-276.
17. Rosen HR, Miner C, Sasaki AW, Lewinsohn DM, Conrad AJ, Bakke A, Bouwer HG, Hinrichs DJ: Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages. Hepatology 2002, 35:190-198.